Oncotelic Therapeutics, Inc. Annual Revenues in USD from 2020 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Oncotelic Therapeutics, Inc. annual/quarterly Revenues history and growth rate from 2020 to 2023.
Oncotelic Therapeutics, Inc. Revenues for the quarter ending September 30, 2023 was $70K.
Oncotelic Therapeutics, Inc. annual Revenues for 2023 was $70K.

Revenues, Annual (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$70K			Jan 1, 2023	Dec 31, 2023	10-K	2024-04-12
2020	$1.74M			Jan 1, 2020	Dec 31, 2020	10-K	2022-04-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.